LifeStance Health Group, Inc.
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
LFST$14.56-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
(In thousands)
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net income (loss) | $709 | $(21,097) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Depreciation and amortization | 13,756 | 22,564 |
| Non-cash operating lease costs | 10,231 | 9,687 |
| Stock-based compensation | 18,584 | 20,581 |
| Amortization of discount and debt issue costs | 251 | 424 |
| Gain on remeasurement of contingent consideration | — | (2,015) |
| Other, net | 357 | (47) |
| Change in operating assets and liabilities, net of businesses acquired: | ||
| Patient accounts receivable, net | (8,568) | (50,532) |
| Prepaid expenses and other current assets | (4,515) | 2,491 |
| Accounts payable | (77) | 4,981 |
| Accrued payroll expenses | (17,540) | (2,045) |
| Operating lease liabilities | (11,894) | (9,608) |
| Other accrued expenses | (4,386) | 2,778 |
| Net cash used in operating activities | $(3,092) | $(21,838) |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||
| Purchases of property and equipment | (7,168) | (5,104) |
| Net cash used in investing activities | $(7,168) | $(5,104) |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Payments of long-term debt | (1,813) | (731) |
| Payments of contingent consideration | — | (1,700) |
| Taxes related to net share settlement of equity awards | (8,162) | — |
| Net cash used in financing activities | $(9,975) | $(2,431) |
| NET DECREASE IN CASH AND CASH EQUIVALENTS | (20,235) | (29,373) |
| Cash and Cash Equivalents - Beginning of period | 154,571 | 78,824 |
| CASH AND CASH EQUIVALENTS – END OF PERIOD | $134,336 | $49,451 |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | ||
| Cash paid for interest, net | $4,382 | $6,270 |
| Cash paid for taxes, net of refunds | $609 | $(252) |
| SUPPLEMENTAL DISCLOSURES OF NON CASH INVESTING AND FINANCING ACTIVITIES | ||
| Acquisition of property and equipment included in liabilities | $2,348 | $3,104 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.